Cite
Arosio G, Sharma GG, Villa M, et al. Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers (Basel). 2021;13(17)doi: 10.3390/cancers13174422.
Arosio, G., Sharma, G. G., Villa, M., Mauri, M., Crespiatico, I., Fontana, D., Manfroni, C., Mastini, C., Zappa, M., Magistroni, V., Ceccon, M., Redaelli, S., Massimino, L., Garbin, A., Lovisa, F., Mussolin, L., Piazza, R., Gambacorti-Passerini, C., & Mologni, L. (2021). Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers, 13(17), . https://doi.org/10.3390/cancers13174422
Arosio, Giulia, et al. "Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma." Cancers vol. 13,17 (2021). doi: https://doi.org/10.3390/cancers13174422
Arosio G, Sharma GG, Villa M, Mauri M, Crespiatico I, Fontana D, Manfroni C, Mastini C, Zappa M, Magistroni V, Ceccon M, Redaelli S, Massimino L, Garbin A, Lovisa F, Mussolin L, Piazza R, Gambacorti-Passerini C, Mologni L. Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers (Basel). 2021 Sep 01;13(17). doi: 10.3390/cancers13174422. PMID: 34503232; PMCID: PMC8431561.
Copy
Download .nbib